Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
The British Journal of Psychiatry. Supplement
|
April 22, 1999
Olanzapine: a basic science update
F Bymaster, K W Perry, D L Nelson, et al.
The Journal of Clinical Psychiatry
|
January 1, 1997
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug
F P Bymaster, K Rasmussen, D O Calligaro, et al.
Arzneimittel-Forschung
|
March 1, 1991
General pharmacology of a new potent 5-hydroxytryptamine antagonist
P D Williams, D O Calligaro, W E Colbert, et al.
Journal of Medicinal Chemistry
|
November 27, 1992
DL-tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy
W H Lunn, D D Schoepp, D O Calligaro, et al.
General Pharmacology
|
May 14, 1999
Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta
B D Sawyer, F P Bymaster, D O Calligaro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 1, 1996
Radioreceptor binding profile of the atypical antipsychotic olanzapine
F P Bymaster, D O Calligaro, J F Falcone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Preclinical studies on LY237733, a potent and selective serotonergic antagonist
M M Foreman, R W Fuller, D L Nelson, et al.
Schizophrenia Research
|
May 5, 1999
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro
F P Bymaster, D L Nelson, N W DeLapp, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity
M M Foreman, R W Fuller, K Rasmussen, et al.
Journal of Medicinal Chemistry
|
September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones
L A McQuaid, E C Smith, K K South, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
The British Journal of Psychiatry. Supplement
|
April 22, 1999
Olanzapine: a basic science update
F Bymaster, K W Perry, D L Nelson, et al.
The Journal of Clinical Psychiatry
|
January 1, 1997
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug
F P Bymaster, K Rasmussen, D O Calligaro, et al.
Arzneimittel-Forschung
|
March 1, 1991
General pharmacology of a new potent 5-hydroxytryptamine antagonist
P D Williams, D O Calligaro, W E Colbert, et al.
Journal of Medicinal Chemistry
|
November 27, 1992
DL-tetrazol-5-ylglycine, a highly potent NMDA agonist: its synthesis and NMDA receptor efficacy
W H Lunn, D D Schoepp, D O Calligaro, et al.
General Pharmacology
|
May 14, 1999
Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta
B D Sawyer, F P Bymaster, D O Calligaro, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 1, 1996
Radioreceptor binding profile of the atypical antipsychotic olanzapine
F P Bymaster, D O Calligaro, J F Falcone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1992
Preclinical studies on LY237733, a potent and selective serotonergic antagonist
M M Foreman, R W Fuller, D L Nelson, et al.
Schizophrenia Research
|
May 5, 1999
Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro
F P Bymaster, D L Nelson, N W DeLapp, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1994
Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity
M M Foreman, R W Fuller, K Rasmussen, et al.
Journal of Medicinal Chemistry
|
September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones
L A McQuaid, E C Smith, K K South, et al.
Page
of 5